Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study [MEETING ABSTRACT PCN140]

Differential change in fatigue in patients treated with sonidegib in BOLT correlated with geographic region, performance status, metastatic burden, and treatment response. Increase in fatigue was lower in patients responding to treatment. These data support the clinical benefit observed with sonidegib in patients with advanced BCC.

Guminski, A., Stull, D., Houghton, K., Gutzmer, R., Migden, MR., Dirix, L., ... Dummer, R. (2016). Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study [MEETING ABSTRACT PCN140]. Value in Health, 19(3), A159-A159. https://doi.org/10.1016/j.jval.2016.03.1474